General Information of the Compound
Compound ID
CP0432979
Compound Name
4-(1-butyl-7-chloro-1H-indazol-3-yl)phenol
    Show/Hide
Synonyms
4-(1-butyl-7-chloro-1H-indazol-3-yl)phenol
    Show/Hide
Structure
Formula
C17H17ClN2O
Molecular Weight
300.789
Canonical SMILES
CCCCn1nc(-c2ccc(O)cc2)c2cccc(Cl)c12
    Show/Hide
InChI
InChI=1S/C17H17ClN2O/c1-2-3-11-20-17-14(5-4-6-15(17)18)16(19-20)12-7-9-13(21)10-8-12/h4-10,21H,2-3,11H2,1H3
    Show/Hide
InChIKey
NPAAZPFDWTWFDL-UHFFFAOYSA-N
Physicochemical Property
logP
4.8624
Rotatable Bonds
4
Heavy Atom Count
21
Polar Areas
38.05
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 135458016
SID: 16889538
ChEMBL ID
CHEMBL385801
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00886, Estrogen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000622 HAECT-1 Homo sapiens (Human)  2
1
EC50 = 63 nM
   TI
   LI
   LO
   TS
2
IC50 = 25 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-(1-butyl-7-chloro-1H-indazol-3-yl)phenol )
Drug Name 4-(1-butyl-7-chloro-1H-indazol-3-yl)phenol
Target(s)
Estrogen receptor (ESR)
Inhibitor